EVKEEZA
Google image searchProduct monograph
Active ingredient
evinacumab, 150 MG/ML
DIN: 02541769
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE USE VIAL
Schedule: Prescription / Schedule D
Company: ULTRAGENYX PHARMACEUTICAL INC
Date: 21-NOV-2023
ATC:
- C10 — LIPID MODIFYING AGENTS (ATC, ATC/DDD, )
- C10A — LIPID MODIFYING AGENTS, PLAIN (ATC, ATC/DDD)
- C10AX — Other lipid modifying agents (ATC, ATC/DDD)
- C10AX17 — EVINACUMAB (ATC/DDD)
Reference brand drug: Evkeeza
